| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Budget Impact Analysis of Utilization of Sacubitril/Valsartan for the Treatment of Heart Failure With Reduced Ejection Fraction in the Philippines
|
Leong, Robert Neil
|
|
|
36 |
C |
p. 105-116
|
artikel
|
| 2 |
Copyright/Subscription
|
|
|
|
36 |
C |
p. v
|
artikel
|
| 3 |
Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R
|
Santos, André S.
|
|
|
36 |
C |
p. 10-17
|
artikel
|
| 4 |
Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong
|
Peng, Kuan
|
|
|
36 |
C |
p. 51-57
|
artikel
|
| 5 |
Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals
|
Oliveira, Layssa Andrade
|
|
|
36 |
C |
p. 34-43
|
artikel
|
| 6 |
Cost-Utility Analysis Comparing Ocrelizumab Versus Rituximab in the Treatment of Relapsing-Remitting Multiple Sclerosis: The Colombian Perspective
|
Navarro, Cristian E.
|
|
|
36 |
C |
p. 83-91
|
artikel
|
| 7 |
Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece
|
Tzanetakos, Charalampos
|
|
|
36 |
C |
p. 18-26
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
36 |
C |
p. i
|
artikel
|
| 9 |
Healthcare Resource Utilization in Controlled Versus Uncontrolled Adults Living With Type 1 Diabetes in the South African Public Healthcare Sector
|
Bhana, Sindeep
|
|
|
36 |
C |
p. 66-75
|
artikel
|
| 10 |
Loss of Health State Utilities Attributable to Obesity
|
Del Río, Francisco
|
|
|
36 |
C |
p. 92-97
|
artikel
|
| 11 |
Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis
|
Buendía, Jefferson Antonio
|
|
|
36 |
C |
p. 44-50
|
artikel
|
| 12 |
Real-World Populational-Based Quality of Life and Functional Status After Stroke
|
Diegoli, Henrique
|
|
|
36 |
C |
p. 76-82
|
artikel
|
| 13 |
Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies?
|
Myung, Jae-Eun
|
|
|
36 |
C |
p. 27-33
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
36 |
C |
p. ii-iv
|
artikel
|
| 15 |
The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage
|
Mangoya, Derek
|
|
|
36 |
C |
p. 1-9
|
artikel
|
| 16 |
Time From Marketing Authorization to Reimbursement of Medicines in Greece After the Introduction of the Health Technology Assessment Process From July 2018 to April 2022
|
Beletsi, Alexandra
|
|
|
36 |
C |
p. 58-65
|
artikel
|
| 17 |
Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in Taiwan
|
Novick, Diego
|
|
|
36 |
C |
p. 98-104
|
artikel
|
Tijdschrift beschrijving